David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 11.76% |
| 3 | Healthcare | 10.16% |
| 4 | Financials | 7.89% |
| 5 | Industrials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
VF Corp
VFC
$5.44B
| $12.2M | 0.01% |
122,500
-116,766
| -49% | -$10.5M |
|
1052
Microchip Technology
MCHP
$39.9B
| $12.2M | 0.01% |
233,058
-582,882
| -71% | -$28.2M |
|
1053
Agios Pharmaceuticals
AGIO
$2.02B
| $12.2M | 0.01% |
254,674
+237,759
| +1,406% | +$8.99M |
|
1054
Bloomin' Brands
BLMN
$945M
| $12.1M | 0.01% |
550,143
-130,159
| -19% | -$2.76M |
|
1055
Assured Guaranty
AGO
$3.3B
| $12.1M | 0.01% |
247,109
+119,351
| +93% | +$5.71M |
|
1056
Atkore
ATKR
$3.16B
| $12.1M | 0.01% |
298,574
+49,892
| +20% | +$1.85M |
|
1057
PUT
DuPont de Nemours
DD
$18.4B
| $12.1M | 0.01% |
149,756
+39,515
| +36% | +$3.28M |
|
|
AMAG
1058
DELISTED
AMAG Pharmaceuticals
AMAG
| $12.1M | 0.01% |
990,553
-5,500
| -0.6% | -$60.1K |
|
1059
CALL
EOG Resources
EOG
$77B
| $12M | 0.01% |
143,700
+16,200
| +13% | +$1.19M |
|
1060
CALL
Essex Property Trust
ESS
$18.8B
| $12M | 0.01% |
40,000
-2,200
| -5% | -$695K |
|
|
JCP
1061
DELISTED
J.C. Penney Company, Inc.
JCP
| $12M | 0.01% |
10,726,562
+2,122,317
| +25% | +$2.25M |
|
1062
iHeartMedia
IHRT
$415M
| $12M | 0.01% |
710,043
| – | – |
|
1063
CALL
Twilio
TWLO
$34.4B
| $12M | 0.01% |
122,100
+8,600
| +8% | +$878K |
|
1064
Zions Bancorporation
ZION
$9.86B
| $12M | 0.01% |
+230,781
| New | +$11.2M |
|
1065
Cameco
CCJ
$46.6B
| $12M | 0.01% |
1,344,494
+655,755
| +95% | +$6.06M |
|
1066
PUT
Bath & Body Works
BBWI
$3.54B
| $12M | 0.01% |
816,544
+228,969
| +39% | +$3.31M |
|
1067
PUT
Ulta Beauty
ULTA
$23.1B
| $11.9M | 0.01% |
47,000
-2,400
| -5% | -$586K |
|
1068
MDU Resources
MDU
$4.2B
| $11.8M | 0.01% |
1,048,046
-71,059
| -6% | -$776K |
|
1069
Fossil Group
FOSL
$323M
| $11.8M | 0.01% |
1,499,511
-62,836
| -4% | -$580K |
|
1070
CALL
Occidental Petroleum
OXY
$58.4B
| $11.8M | 0.01% |
285,575
+8,800
| +3% | +$353K |
|
1071
Haemonetics
HAE
$4.93B
| $11.8M | 0.01% |
102,374
+74,825
| +272% | +$9.05M |
|
|
TPH
1072
DELISTED
Tri Pointe Homes
TPH
| $11.7M | 0.01% |
752,849
+258,522
| +52% | +$3.98M |
|
|
IMMU
1073
DELISTED
Immunomedics Inc
IMMU
| $11.7M | 0.01% |
553,638
+408,034
| +280% | +$7.2M |
|
|
ATVI
1074
PUT
DELISTED
Activision Blizzard
ATVI
| $11.7M | 0.01% |
197,100
-9,800
| -5% | -$543K |
|
1075
CALL
Edwards Lifesciences
EW
$52.4B
| $11.7M | 0.01% |
150,600
+10,800
| +8% | +$843K |
|
Similar funds
David Shaw's Q4 2019 Portfolio in Review
As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- David Shaw opened 572 new positions and closed 412 in Q4 2019.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.